id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-V-0385-0004,FDA,FDA-2022-V-0385,Variance Renewal Application from Brant Parrish,Other,Application for Variance (VAR),2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T18:02:11Z,,0,0,09000064b92d6cc8
FDA-2022-V-0385-0003,FDA,FDA-2022-V-0385,Variance Approval Letter from FDA CDRH to Brant Parrish,Other,Approval for Variance (VRA),2022-04-18T04:00:00Z,2022,4,2022-04-18T04:00:00Z,,2022-04-18T11:51:35Z,,0,0,090000648501f4d7
FDA-2022-V-0385-0001,FDA,FDA-2022-V-0385,Variance Application from Brant Parrish,Other,Application for Variance (VAR),2022-03-28T04:00:00Z,2022,3,2022-03-28T04:00:00Z,,2022-03-28T19:25:34Z,,0,0,0900006484fd8a63
FDA-2022-V-0385-0002,FDA,FDA-2022-V-0385,Acknowledgment Letter from FDA DMS to Brant Parrish,Other,Acknowledgement Letter/Receipt,2022-03-28T04:00:00Z,2022,3,2022-03-28T04:00:00Z,,2022-03-28T19:27:41Z,,0,0,0900006484fd8a65